Sanjay Nayak - 22 Feb 2024 Form 4 Insider Report for OCULAR THERAPEUTIX, INC (OCUL)

Role: Chief Strategy Officer
Signature: /s/ Donald Notman, Attorney-in-Fact for Sanjay Nayak
Issuer symbol: OCUL
Transactions as of: 22 Feb 2024
Net transactions value: $0
Form type: 4
Filing time: 26 Feb 2024, 20:06:32 UTC
Previous filing: 26 Feb 2024
Next filing: 28 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCUL	Common Stock	Award	$0	+80,300	+80%	$0.000000	180,300	22 Feb 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCUL	Stock Option (Right to Buy)	Award	$0	+244,550		$0.000000	244,550	22 Feb 2024	Common Stock	244,550	$9.70	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 22, 2024, the reporting person was granted restricted stock units ("RSUs") under the 2019 Inducement Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, in equal quarterly installments, beginning on the date of grant.
F2	Vests over four years, with 1/4 of the shares underlying the option vesting on the one-year anniversary of the date the reporting person commenced employment with the Corporation and 1/48 of the shares underlying the option vesting monthly thereafter.

Content

On February 22, 2024, the reporting person was granted restricted stock units ("RSUs") under the 2019 Inducement Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, in equal quarterly installments, beginning on the date of grant.

Vests over four years, with 1/4 of the shares underlying the option vesting on the one-year anniversary of the date the reporting person commenced employment with the Corporation and 1/48 of the shares underlying the option vesting monthly thereafter.